Literature DB >> 25732601

Generation, cryopreservation, function and in vivo persistence of ex vivo expanded cynomolgus monkey regulatory T cells.

Hao Guo1, Hong Zhang1, Lien Lu1, Mohamed B Ezzelarab1, Angus W Thomson2.   

Abstract

We expanded flow-sorted Foxp3(+) cynomolgus monkey regulatory T cells (Treg) >1000-fold after three rounds of stimulation with anti-CD3 mAb-loaded artificial antigen-presenting cells, rapamycin (first round only) and IL-2. The expanded Treg maintained their expression of Treg signature markers, CD25, CD27, CD39, Foxp3, Helios, and CTLA-4, as well as CXCR3, which plays an important role in T cell migration to sites of inflammation. In contrast to expanded effector T cells (Teff), expanded Treg produced minimal IFN-γ and IL-17 and no IL-2 and potently suppressed Teff proliferation. Following cryopreservation, thawed Treg were less viable than their freshly-expanded counterparts, although no significant changes in phenotype or suppressive ability were observed. Additional rounds of stimulation/expansion restored maximal viability. Furthermore, adoptively-transferred autologous Treg expanded from cryopreserved second round stocks and labeled with CFSE or VPD450 were detected in blood and secondary lymphoid tissues of normal or immunosuppressed recipients at least two months after their systemic infusion.
Copyright © 2015 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Cryopreservation; Cynomolgus macaques; Ex vivo expansion; In vivo monitoring; Regulatory T cells

Mesh:

Substances:

Year:  2015        PMID: 25732601      PMCID: PMC4405464          DOI: 10.1016/j.cellimm.2015.02.006

Source DB:  PubMed          Journal:  Cell Immunol        ISSN: 0008-8749            Impact factor:   4.868


  53 in total

1.  Expression of CD39 by human peripheral blood CD4+ CD25+ T cells denotes a regulatory memory phenotype.

Authors:  K M Dwyer; D Hanidziar; P Putheti; P A Hill; S Pommey; J L McRae; A Winterhalter; G Doherty; S Deaglio; M Koulmanda; W Gao; S C Robson; T B Strom
Journal:  Am J Transplant       Date:  2010-11       Impact factor: 8.086

2.  Expanded nonhuman primate tregs exhibit a unique gene expression signature and potently downregulate alloimmune responses.

Authors:  A Anderson; C L Martens; R Hendrix; L L Stempora; W P Miller; K Hamby; M Russell; E Strobert; B R Blazar; T C Pearson; C P Larsen; L S Kean
Journal:  Am J Transplant       Date:  2008-09-17       Impact factor: 8.086

Review 3.  Rabbit antithymocyte globulin (thymoglobulin): 25 years and new frontiers in solid organ transplantation and haematology.

Authors:  A Osama Gaber; Anthony P Monaco; James A Russell; Yvon Lebranchu; Mohamad Mohty
Journal:  Drugs       Date:  2010-04-16       Impact factor: 9.546

4.  Mammalian target of rapamycin inhibition and alloantigen-specific regulatory T cells synergize to promote long-term graft survival in immunocompetent recipients.

Authors:  Giorgio Raimondi; Tina L Sumpter; Benjamin M Matta; Mahesh Pillai; Natasha Corbitt; Yoram Vodovotz; Zhiliang Wang; Angus W Thomson
Journal:  J Immunol       Date:  2009-12-09       Impact factor: 5.422

5.  Optimization and limitations of use of cryopreserved peripheral blood mononuclear cells for functional and phenotypic T-cell characterization.

Authors:  Adriana Weinberg; Lin-Ye Song; Cynthia Wilkening; Anne Sevin; Bruce Blais; Raul Louzao; Dana Stein; Patricia Defechereux; Deborah Durand; Eric Riedel; Nancy Raftery; Renee Jesser; Betty Brown; M Fran Keller; Ruth Dickover; Elizabeth McFarland; Terence Fenton
Journal:  Clin Vaccine Immunol       Date:  2009-06-10

6.  Recipient-type specific CD4+CD25+ regulatory T cells favor immune reconstitution and control graft-versus-host disease while maintaining graft-versus-leukemia.

Authors:  Aurélie Trenado; Frédéric Charlotte; Sylvain Fisson; Micael Yagello; David Klatzmann; Benoit L Salomon; José L Cohen
Journal:  J Clin Invest       Date:  2003-12       Impact factor: 14.808

7.  First-in-man clinical results of the treatment of patients with graft versus host disease with human ex vivo expanded CD4+CD25+CD127- T regulatory cells.

Authors:  Piotr Trzonkowski; Maria Bieniaszewska; Jolanta Juścińska; Anita Dobyszuk; Adam Krzystyniak; Natalia Marek; Jolanta Myśliwska; Andrzej Hellmann
Journal:  Clin Immunol       Date:  2009-06-25       Impact factor: 3.969

8.  Regulatory T cells sequentially migrate from inflamed tissues to draining lymph nodes to suppress the alloimmune response.

Authors:  Nan Zhang; Bernd Schröppel; Girdhari Lal; Claudia Jakubzick; Xia Mao; Dan Chen; Na Yin; Rolf Jessberger; Jordi C Ochando; Yaozhong Ding; Jonathan S Bromberg
Journal:  Immunity       Date:  2009-03-20       Impact factor: 31.745

9.  The transcription factor T-bet controls regulatory T cell homeostasis and function during type 1 inflammation.

Authors:  Meghan A Koch; Glady's Tucker-Heard; Nikole R Perdue; Justin R Killebrew; Kevin B Urdahl; Daniel J Campbell
Journal:  Nat Immunol       Date:  2009-05-03       Impact factor: 25.606

10.  Clinical grade Treg: GMP isolation, improvement of purity by CD127 Depletion, Treg expansion, and Treg cryopreservation.

Authors:  Jorieke H Peters; Frank W Preijers; Rob Woestenenk; Luuk B Hilbrands; Hans J P M Koenen; Irma Joosten
Journal:  PLoS One       Date:  2008-09-08       Impact factor: 3.240

View more
  13 in total

1.  Adoptive Cell Therapy with Tregs to Improve Transplant Outcomes: The Promise and the Stumbling Blocks.

Authors:  Mohamed B Ezzelarab; Angus W Thomson
Journal:  Curr Transplant Rep       Date:  2016-10-25

2.  A method for expansion of T cells from cynomolgus monkey (Macaca fascicularis).

Authors:  Change Gao; Qian Song; Ming Zhang; Jian Li; Miao Yi; Jian Dong
Journal:  In Vitro Cell Dev Biol Anim       Date:  2018-08-15       Impact factor: 2.416

Review 3.  Transplant research in nonhuman primates to evaluate clinically relevant immune strategies in organ transplantation.

Authors:  Zachary Fitch; Robin Schmitz; Jean Kwun; Bernhard Hering; Joren Madsen; Stuart J Knechtle
Journal:  Transplant Rev (Orlando)       Date:  2019-04-05       Impact factor: 3.943

4.  The Pursuit of Regulatory T Cells in the Induction of Transplant Tolerance.

Authors:  Preston R Arnold; Xian C Li
Journal:  Adv Exp Med Biol       Date:  2021       Impact factor: 2.622

5.  Regulatory T Cell Infusion Can Enhance Memory T Cell and Alloantibody Responses in Lymphodepleted Nonhuman Primate Heart Allograft Recipients.

Authors:  M B Ezzelarab; H Zhang; H Guo; L Lu; A F Zahorchak; R W Wiseman; M A Nalesnik; J K Bhama; D K C Cooper; A W Thomson
Journal:  Am J Transplant       Date:  2016-03-17       Impact factor: 8.086

6.  Ex Vivo Expanded Donor Alloreactive Regulatory T Cells Lose Immunoregulatory, Proliferation, and Antiapoptotic Markers After Infusion Into ATG-lymphodepleted, Nonhuman Primate Heart Allograft Recipients.

Authors:  Mohamed B Ezzelarab; Hong Zhang; Kazuki Sasaki; Lien Lu; Alan F Zahorchak; Dirk J van der Windt; Helong Dai; Angelica Perez-Gutierrez; Jay K Bhama; Angus W Thomson
Journal:  Transplantation       Date:  2021-09-01       Impact factor: 5.385

7.  Cell banking for regulatory T cell-based therapy: strategies to overcome the impact of cryopreservation on the Treg viability and phenotype.

Authors:  Karolina Gołąb; Randall Grose; Veronica Placencia; Amittha Wickrema; Julia Solomina; Martin Tibudan; Evelyn Konsur; Kamil Ciepły; Natalia Marek-Trzonkowska; Piotr Trzonkowski; J Michael Millis; John Fung; Piotr Witkowski
Journal:  Oncotarget       Date:  2018-01-03

Review 8.  Tregs and Mixed Chimerism as Approaches for Tolerance Induction in Islet Transplantation.

Authors:  Shiva Pathak; Everett H Meyer
Journal:  Front Immunol       Date:  2021-01-29       Impact factor: 7.561

9.  CD40L-stimulated B cells for ex-vivo expansion of polyspecific non-human primate regulatory T cells for translational studies.

Authors:  P Alonso-Guallart; N Llore; E Lopes; S-B Kofman; S-H Ho; J Stern; G Pierre; K Bruestle; Q Tang; M Sykes; A Griesemer
Journal:  Clin Exp Immunol       Date:  2020-12-28       Impact factor: 5.732

10.  Applicability, safety, and biological activity of regulatory T cell therapy in liver transplantation.

Authors:  Alberto Sánchez-Fueyo; Gavin Whitehouse; Nathali Grageda; Matthew E Cramp; Tiong Y Lim; Marco Romano; Sarah Thirkell; Katie Lowe; Laura Fry; Julie Heward; Alex Kerr; Jakia Ali; Chris Fisher; Gillian Lewis; Andrew Hope; Elisavet Kodela; Mike Lyne; Farzin Farzaneh; Shahram Kordasti; Irene Rebollo-Mesa; Juan Jose Lozano; Niloufar Safinia; Nigel Heaton; Robert Lechler; Marc Martínez-Llordella; Giovanna Lombardi
Journal:  Am J Transplant       Date:  2020-02-03       Impact factor: 8.086

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.